| Year |
Citation |
Score |
| 2024 |
Okubo T, Rivron N, Kabata M, Masaki H, Kishimoto K, Semi K, Nakajima-Koyama M, Kunitomi H, Kaswandy B, Sato H, Nakauchi H, Woltjen K, Saitou M, Sasaki E, Yamamoto T, et al. Publisher Correction: Hypoblast from human pluripotent stem cells regulates epiblast development. Nature. 626: E21. PMID 38347193 DOI: 10.1038/s41586-024-07166-w |
0.385 |
|
| 2023 |
Okubo T, Rivron N, Kabata M, Masaki H, Kishimoto K, Semi K, Nakajima-Koyama M, Kunitomi H, Kaswandy B, Sato H, Nakauchi H, Woltjen K, Saitou M, Sasaki E, Yamamoto T, et al. Hypoblast from human pluripotent stem cells regulates epiblast development. Nature. PMID 38052228 DOI: 10.1038/s41586-023-06871-2 |
0.362 |
|
| 2023 |
Otomo J, Woltjen K, Sakurai H. Uniform transgene activation in Tet-On systems depends on sustained rtTA expression. Iscience. 26: 107685. PMID 37701566 DOI: 10.1016/j.isci.2023.107685 |
0.361 |
|
| 2023 |
Kubiura-Ichimaru M, Penfold C, Kojima K, Dollet C, Yabukami H, Semi K, Takashima Y, Boroviak T, Kawaji H, Woltjen K, Minoda A, Sasaki E, Watanabe T. mRNA-based generation of marmoset PGCLCs capable of differentiation into gonocyte-like cells. Stem Cell Reports. 18: 1987-2002. PMID 37683645 DOI: 10.1016/j.stemcr.2023.08.006 |
0.411 |
|
| 2022 |
Ueda T, Shiina S, Iriguchi S, Terakura S, Kawai Y, Kabai R, Sakamoto S, Watanabe A, Ohara K, Wang B, Xu H, Minagawa A, Hotta A, Woltjen K, Uemura Y, et al. Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells. Nature Biomedical Engineering. 7: 24-37. PMID 36509913 DOI: 10.1038/s41551-022-00969-0 |
0.304 |
|
| 2021 |
Taguchi J, Shibata H, Kabata M, Kato M, Fukuda K, Tanaka A, Ohta S, Ukai T, Mitsunaga K, Yamada Y, Nagaoka SI, Yamazawa S, Ohnishi K, Woltjen K, Ushiku T, et al. DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotency. Nature Communications. 12: 5041. PMID 34413299 DOI: 10.1038/s41467-021-25249-4 |
0.325 |
|
| 2021 |
Io S, Kabata M, Iemura Y, Semi K, Morone N, Minagawa A, Wang B, Okamoto I, Nakamura T, Kojima Y, Iwatani C, Tsuchiya H, Kaswandy B, Kondoh E, Kaneko S, ... Woltjen K, et al. Capturing human trophoblast development with naive pluripotent stem cells in vitro. Cell Stem Cell. PMID 33831365 DOI: 10.1016/j.stem.2021.03.013 |
0.312 |
|
| 2020 |
Maurissen TL, Woltjen K. Synergistic gene editing in human iPS cells via cell cycle and DNA repair modulation. Nature Communications. 11: 2876. PMID 32513994 DOI: 10.1038/s41467-020-16643-5 |
0.316 |
|
| 2020 |
Matsuda M, Yamanaka Y, Uemura M, Osawa M, Saito MK, Nagahashi A, Nishio M, Guo L, Ikegawa S, Sakurai S, Kihara S, Maurissen TL, Nakamura M, Matsumoto T, Yoshitomi H, ... ... Woltjen K, et al. Recapitulating the human segmentation clock with pluripotent stem cells. Nature. 580: 124-129. PMID 32238941 DOI: 10.1038/s41586-020-2144-9 |
0.382 |
|
| 2019 |
Sakakura M, Ohta S, Yagi M, Tanaka A, Norihide J, Woltjen K, Yamamoto T, Yamada Y. Smarcb1 maintains the cellular identity and the chromatin landscapes of mouse embryonic stem cells. Biochemical and Biophysical Research Communications. PMID 31543342 DOI: 10.1016/j.bbrc.2019.09.054 |
0.358 |
|
| 2019 |
Komura S, Ito K, Ohta S, Ukai T, Kabata M, Itakura F, Semi K, Matsuda Y, Hashimoto K, Shibata H, Sone M, Jo N, Sekiguchi K, Ohno T, Akiyama H, ... ... Woltjen K, et al. Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas. Nature Communications. 10: 3999. PMID 31488818 DOI: 10.1038/S41467-019-11745-1 |
0.349 |
|
| 2018 |
Kagawa H, Shimamoto R, Kim SI, Oceguera-Yanez F, Yamamoto T, Schroeder T, Woltjen K. OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates. Stem Cell Reports. PMID 30639212 DOI: 10.1016/j.stemcr.2018.12.008 |
0.421 |
|
| 2018 |
Kim SI, Matsumoto T, Kagawa H, Nakamura M, Hirohata R, Ueno A, Ohishi M, Sakuma T, Soga T, Yamamoto T, Woltjen K. Microhomology-assisted scarless genome editing in human iPSCs. Nature Communications. 9: 939. PMID 29507284 DOI: 10.1038/s41467-018-03044-y |
0.339 |
|
| 2017 |
Kojima Y, Sasaki K, Yokobayashi S, Sakai Y, Nakamura T, Yabuta Y, Nakaki F, Nagaoka S, Woltjen K, Hotta A, Yamamoto T, Saitou M. Evolutionarily Distinctive Transcriptional and Signaling Programs Drive Human Germ Cell Lineage Specification from Pluripotent Stem Cells. Cell Stem Cell. 21: 517-532.e5. PMID 28985527 DOI: 10.1016/J.Stem.2017.09.005 |
0.374 |
|
| 2017 |
Kieffer TJ, Woltjen K, Osafune K, Yabe D, Inagaki N. Beta-cell replacement strategies for diabetes. Journal of Diabetes Investigation. PMID 28984038 DOI: 10.1111/jdi.12758 |
0.318 |
|
| 2016 |
Komura S, Semi K, Itakura F, Shibata H, Ohno T, Hotta A, Woltjen K, Yamamoto T, Akiyama H, Yamada Y. An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma Development. Stem Cell Reports. PMID 26997645 DOI: 10.1016/J.Stemcr.2016.02.009 |
0.319 |
|
| 2015 |
Oceguera-Yanez F, Kim SI, Matsumoto T, Tan GW, Long X, Hatani T, Kondo T, Ikeya M, Yoshida Y, Inoue H, Woltjen K. Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives. Methods (San Diego, Calif.). PMID 26707206 DOI: 10.1016/j.ymeth.2015.12.012 |
0.41 |
|
| 2015 |
Tamaki S, Fukuta M, Sekiguchi K, Jin Y, Nagata S, Hayakawa K, Hineno S, Okamoto T, Watanabe M, Woltjen K, Ikeya M, Kato T, Toguchida J. SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier. Plos One. 10: e0142991. PMID 26571495 DOI: 10.1371/journal.pone.0142991 |
0.321 |
|
| 2015 |
Chantzoura E, Skylaki S, Menendez S, Kim SI, Johnsson A, Linnarsson S, Woltjen K, Chambers I, Kaji K. Reprogramming Roadblocks Are System Dependent. Stem Cell Reports. 5: 350-64. PMID 26278041 DOI: 10.1016/J.Stemcr.2015.07.007 |
0.306 |
|
| 2015 |
Sasaki K, Yokobayashi S, Nakamura T, Okamoto I, Yabuta Y, Kurimoto K, Ohta H, Moritoki Y, Iwatani C, Tsuchiya H, Nakamura S, Sekiguchi K, Sakuma T, Yamamoto T, Mori T, ... Woltjen K, et al. Robust In Vitro Induction of Human Germ Cell Fate from Pluripotent Stem Cells. Cell Stem Cell. 17: 178-94. PMID 26189426 DOI: 10.1016/j.stem.2015.06.014 |
0.396 |
|
| 2015 |
Woltjen K, Kim SI, Nagy A. The piggyBac Transposon as a Platform Technology for Somatic Cell Reprogramming Studies in Mouse. Methods in Molecular Biology (Clifton, N.J.). PMID 26126450 DOI: 10.1007/7651_2015_274 |
0.55 |
|
| 2015 |
Kim SI, Oceguera-Yanez F, Sakurai C, Nakagawa M, Yamanaka S, Woltjen K. Inducible Transgene Expression in Human iPS Cells Using Versatile All-in-One piggyBac Transposons. Methods in Molecular Biology (Clifton, N.J.). PMID 26025620 DOI: 10.1007/7651_2015_251 |
0.463 |
|
| 2015 |
Shoji E, Woltjen K, Sakurai H. Directed Myogenic Differentiation of Human Induced Pluripotent Stem Cells. Methods in Molecular Biology (Clifton, N.J.). PMID 25971915 DOI: 10.1007/7651_2015_257 |
0.416 |
|
| 2014 |
Ohnishi K, Semi K, Yamamoto T, Shimizu M, Tanaka A, Mitsunaga K, Okita K, Osafune K, Arioka Y, Maeda T, Soejima H, Moriwaki H, Yamanaka S, Woltjen K, Yamada Y. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell. 156: 663-77. PMID 24529372 DOI: 10.1016/j.cell.2014.01.005 |
0.301 |
|
| 2013 |
Yamashita A, Liu S, Woltjen K, Thomas B, Meng G, Hotta A, Takahashi K, Ellis J, Yamanaka S, Rancourt DE. Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells. Scientific Reports. 3: 1978. PMID 23760219 DOI: 10.1038/srep01978 |
0.586 |
|
| 2013 |
Tanaka A, Woltjen K, Miyake K, Hotta A, Ikeya M, Yamamoto T, Nishino T, Shoji E, Sehara-Fujisawa A, Manabe Y, Fujii N, Hanaoka K, Era T, Yamashita S, Isobe K, et al. Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro. Plos One. 8: e61540. PMID 23626698 DOI: 10.1371/journal.pone.0061540 |
0.389 |
|
| 2013 |
Sakuma T, Hosoi S, Woltjen K, Suzuki K, Kashiwagi K, Wada H, Ochiai H, Miyamoto T, Kawai N, Sasakura Y, Matsuura S, Okada Y, Kawahara A, Hayashi S, Yamamoto T. Efficient TALEN construction and evaluation methods for human cell and animal applications. Genes to Cells : Devoted to Molecular & Cellular Mechanisms. 18: 315-26. PMID 23388034 DOI: 10.1111/gtc.12037 |
0.392 |
|
| 2013 |
Hayakawa K, Ikeya M, Fukuta M, Woltjen K, Tamaki S, Takahara N, Kato T, Sato S, Otsuka T, Toguchida J. Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells. Biochemical and Biophysical Research Communications. 432: 713-9. PMID 23313505 DOI: 10.1016/j.bbrc.2013.01.003 |
0.364 |
|
| 2012 |
Michael IP, Monetti C, Chiu AC, Zhang P, Baba T, Nishino K, Agha-Mohammadi S, Woltjen K, Sung HK, Nagy A. Highly efficient site-specific transgenesis in cancer cell lines. Molecular Cancer. 11: 89. PMID 23231822 DOI: 10.1186/1476-4598-11-89 |
0.454 |
|
| 2011 |
Gabut M, Samavarchi-Tehrani P, Wang X, Slobodeniuc V, O'Hanlon D, Sung HK, Alvarez M, Talukder S, Pan Q, Mazzoni EO, Nedelec S, Wichterle H, Woltjen K, Hughes TR, Zandstra PW, et al. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell. 147: 132-46. PMID 21924763 DOI: 10.1016/J.Cell.2011.08.023 |
0.526 |
|
| 2011 |
Woltjen K, Hämäläinen R, Kibschull M, Mileikovsky M, Nagy A. Transgene-free production of pluripotent stem cells using piggyBac transposons. Methods in Molecular Biology (Clifton, N.J.). 767: 87-103. PMID 21822869 DOI: 10.1007/978-1-61779-201-4_7 |
0.599 |
|
| 2011 |
Nagy K, Sung HK, Zhang P, Laflamme S, Vincent P, Agha-Mohammadi S, Woltjen K, Monetti C, Michael IP, Smith LC, Nagy A. Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Reviews. 7: 693-702. PMID 21347602 DOI: 10.1007/S12015-011-9239-5 |
0.57 |
|
| 2011 |
Monetti C, Nishino K, Biechele S, Zhang P, Baba T, Woltjen K, Nagy A. PhiC31 integrase facilitates genetic approaches combining multiple recombinases. Methods (San Diego, Calif.). 53: 380-5. PMID 21185379 DOI: 10.1016/J.Ymeth.2010.12.023 |
0.527 |
|
| 2010 |
Samavarchi-Tehrani P, Golipour A, David L, Sung HK, Beyer TA, Datti A, Woltjen K, Nagy A, Wrana JL. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell. 7: 64-77. PMID 20621051 DOI: 10.1016/J.Stem.2010.04.015 |
0.512 |
|
| 2010 |
O'Malley J, Woltjen K, Kaji K. New strategies to generate induced pluripotent stem cells. Current Opinion in Biotechnology. 20: 516-21. PMID 19837580 DOI: 10.1016/j.copbio.2009.09.005 |
0.434 |
|
| 2009 |
Woltjen K, Stanford WL. Preview. Inhibition of Tgf-beta signaling improves mouse fibroblast reprogramming. Cell Stem Cell. 5: 457-8. PMID 19896434 DOI: 10.1016/J.Stem.2009.10.007 |
0.351 |
|
| 2009 |
Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämäläinen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung HK, Nagy A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 458: 766-70. PMID 19252478 DOI: 10.1038/Nature07863 |
0.637 |
|
| 2009 |
Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature. 458: 771-5. PMID 19252477 DOI: 10.1038/nature07864 |
0.489 |
|
| 2008 |
Woltjen K, Ito K, Tsuzuki T, Rancourt DE. Orpheus recombination : a comprehensive bacteriophage system for murine targeting vector construction by transplacement. Methods in Molecular Biology (Clifton, N.J.). 435: 79-94. PMID 18370069 DOI: 10.1007/978-1-59745-232-8_6 |
0.533 |
|
| 2003 |
Thomas B, Woltjen K, Rancourt DE. Deep screening of recombination proficient bacteriophage libraries. Biotechniques. 34: 36-8, 40. PMID 12545535 |
0.469 |
|
| 2002 |
Woltjen K, Unger MW, Rancourt DE. Transplacement mutagenesis. A recombination-based in situ mutagenesis protocol. Methods in Molecular Biology (Clifton, N.J.). 182: 189-207. PMID 11768965 |
0.516 |
|
| Show low-probability matches. |